What does Viva Salud do?

Viva Salud is filed with the CBE under the catch-all “Verenigingen op het vlak van ontwikkelingssamenwerking”, a code that says little about what the company actually does. Non-profit, started on 1 February 1978, 1 establishment.

What is the address of Viva Salud?

The registered office of Viva Salud is located at Haachtse Steenweg 53, 1210 Sint-Joost-ten-Node.

Is Viva Salud still active?

Yes. According to the CBE (29 October 2026) Viva Salud is active, legal situation “Normale toestand”, started on 1 February 1978.

Is Viva Salud registered on Peppol?

Yes, Viva Salud is registered on the Peppol network with ID 0208:0418282311.

What is the enterprise number of Viva Salud?

The enterprise number of Viva Salud is BE0418282311.

When was Viva Salud founded?

Viva Salud was founded on 1 February 1978.

Who are the directors of Viva Salud?

According to the 2025 annual accounts, the directors of Viva Salud are: Anuschka Mahieu, Marc Botenga, Micheline Bruyninckx, Wim De Ceukelaire, Isabelle Vanbrabant, 2C&B (B00413).

Is Viva Salud a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 February 1978; 5 annual accounts filed, latest fiscal year 2025; 6 directors known from the annual account.

How much profit did Viva Salud make in 2025?

Viva Salud posted a profit after taxes of € 147,515 in financial year 2025.

What is the revenue of Viva Salud?

In its most recent annual accounts (2025), Viva Salud reported revenue of € 25,037.

How much does an employee at Viva Salud earn?

The average wage cost per full-time employee at Viva Salud was € 54,300 in 2025: staff costs of € 814,559 for 15 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Viva Salud have?

According to the 2025 annual accounts, Viva Salud has 15 full-time equivalents (FTE).

Does Viva Salud have a website?

Yes, Viva Salud has a website at vivasalud.be.

Viva Salud (Non-profit) - Sint-Joost-ten-Node

Dossier Viva Salud, printed on 29 October 2026 from databakkes.be/en/0418282311/viva-salud. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Viva Salud from Sint-Joost-ten-Node, company number BE0418282311, closed financial year 2025 with a result of € 147,515 after tax. For that financial year Viva Salud recorded revenue of € 25,037 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 12,218 to € 147,515. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 16, 2026.

What it is worth Growing

€ 1.1 million

▲ 16% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 147,515

▲ € 135,296 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 777,797

▼ 25% vs 2024

Cash and bank balances on the last day of the fiscal year.

People and assets in 2025

Full-time equivalents

▼ 1.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 814,559

▼ 2% vs 2024

€ 54,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 3,285

▼ 38% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 43,003

▼ 44% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 69,189

▲ 13% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 37,631 Revenue 2022: € 37,631 First fiscal year in the series	€ 49,341 Revenue 2023: € 49,341 ▲ 31% vs 2022 (€ 37,631) Favourable step	€ 159,166 Revenue 2024: € 159,166 ▲ 223% vs 2023 (€ 49,341) Favourable step	€ 25,037 Revenue 2025: € 25,037 ▼ 84% vs 2024 (€ 159,166) Unfavourable step	▼ 84%
Gross margin	€ 1,355,380 Gross margin 2022: € 1,355,380 First fiscal year in the series	€ 2,186,047 Gross margin 2023: € 2,186,047 ▲ 61% vs 2022 (€ 1,355,380) Favourable step	€ 2,027,060 Gross margin 2024: € 2,027,060 ▼ 7% vs 2023 (€ 2,186,047) Unfavourable step	€ 1,899,827 Gross margin 2025: € 1,899,827 ▼ 6% vs 2024 (€ 2,027,060) Unfavourable step	▼ 6%
Profit after taxes	€ 37,994 Profit after taxes 2022: € 37,994 First fiscal year in the series	€ 99,624 Profit after taxes 2023: € 99,624 ▲ 162% vs 2022 (€ 37,994) Favourable step	€ 12,218 Profit after taxes 2024: € 12,218 ▼ 88% vs 2023 (€ 99,624) Unfavourable step	€ 147,515 Profit after taxes 2025: € 147,515 ▲ € 135,296 vs 2024 (€ 12,218) Favourable step	▲ € 135,296
Equity	€ 795,859 Equity 2022: € 795,859 First fiscal year in the series	€ 895,482 Equity 2023: € 895,482 ▲ 13% vs 2022 (€ 795,859) Favourable step	€ 907,701 Equity 2024: € 907,701 ▲ 1% vs 2023 (€ 895,482) Favourable step	€ 1,055,216 Equity 2025: € 1,055,216 ▲ 16% vs 2024 (€ 907,701) Favourable step	▲ 16%
Total debts	€ 5,140,614 Total debts 2022: € 5,140,614 First fiscal year in the series	€ 3,958,343 Total debts 2023: € 3,958,343 ▼ 23% vs 2022 (€ 5,140,614) Favourable step	€ 2,947,857 Total debts 2024: € 2,947,857 ▼ 26% vs 2023 (€ 3,958,343) Favourable step	€ 1,415,815 Total debts 2025: € 1,415,815 ▼ 52% vs 2024 (€ 2,947,857) Favourable step	▼ 52%
Cash	€ 1,269,272 Cash 2022: € 1,269,272 First fiscal year in the series	€ 1,194,934 Cash 2023: € 1,194,934 ▼ 6% vs 2022 (€ 1,269,272) Unfavourable step	€ 1,033,757 Cash 2024: € 1,033,757 ▼ 13% vs 2023 (€ 1,194,934) Unfavourable step	€ 777,797 Cash 2025: € 777,797 ▼ 25% vs 2024 (€ 1,033,757) Unfavourable step	▼ 25%
Retained profit	€ 795,859 Retained profit 2022: € 795,859 First fiscal year in the series	€ 895,482 Retained profit 2023: € 895,482 ▲ 13% vs 2022 (€ 795,859) Favourable step	€ 907,701 Retained profit 2024: € 907,701 ▲ 1% vs 2023 (€ 895,482) Favourable step	€ 1,055,216 Retained profit 2025: € 1,055,216 ▲ 16% vs 2024 (€ 907,701) Favourable step	▲ 16%
Balance sheet total	€ 5,985,492 Balance sheet total 2022: € 5,985,492 First fiscal year in the series	€ 4,908,563 Balance sheet total 2023: € 4,908,563 ▼ 18% vs 2022 (€ 5,985,492) Unchanged	€ 3,910,296 Balance sheet total 2024: € 3,910,296 ▼ 20% vs 2023 (€ 4,908,563) Unchanged	€ 2,535,707 Balance sheet total 2025: € 2,535,707 ▼ 35% vs 2024 (€ 3,910,296) Unchanged	▼ 35%
Employees (FTE)	12.9 Employees (FTE) 2022: 12.9 First fiscal year in the series	13.6 Employees (FTE) 2023: 13.6 ▲ 0.7 vs 2022 (12.9) Unchanged	16.6 Employees (FTE) 2024: 16.6 ▲ 3 vs 2023 (13.6) Unchanged	15 Employees (FTE) 2025: 15 ▼ 1.6 vs 2024 (16.6) Unchanged	▼ 1.6

Key figures of Viva Salud, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Viva Salud?

What happened at Viva Salud in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Anuschka Mahieu stepped down as director. NBB
2029 Micheline Bruyninckx stepped down as director. NBB
2026 2C&B (B00413) stepped down as director. NBB
Jun 16, 2026 New annual accounts for financial year 2025: profit of € 147,515 (▲ € 135,296 vs 2024). Source: NBB ↗
2025 Anuschka Mahieu became a director. NBB
2025 Micheline Bruyninckx became a director. NBB
2024 Marc Botenga stepped down as director. NBB
2024 Wim De Ceukelaire stepped down as director. NBB

In short

From € 37,994 profit in 2022 to € 147,515 profit in 2025.

Paid € 21,679 in corporate taxes since 2022.

Best year ever: 2025, with € 147,515 profit.

On average € 126,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

Anuschka Mahieu

Director

since 2025 · until 2029

Marc Botenga

Chairman of the board

since 2020 · until 2024

Micheline Bruyninckx

Director

since 2025 · until 2029

Wim De Ceukelaire

Director

since 2020 · until 2024

Isabelle Vanbrabant

Director

since 2020 · until 2024

2C&B (B00413)

Auditor · represented by Emmanuel Collin

Also active at: COUPLET SUGARS, ALPINTER

since 2023 · until 2026

Establishments

Establishment units

Physical locations of this company

Registered office

Haachtse Steenweg 53

1210 Sint-Joost-ten-Node

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.

All companies at this address →

Globalize Solidarity

Bisan International Center for research and development

Platform 'Allochtone' Studenten

ibon INTERNATIONAL europe

Research Should Not Kill vzw

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS vivasalud.be

Canonical: https://www.vivasalud.be/

Technologies

ApacheElementorGoogle AnalyticsGoogle FontsPHPSwiperTranslatePressWordPressjQueryjQuery UIlazysizes

Hosting & Email

Email provider

Self-hosted

Hosting

INFOMANIAK-AS, CH

DNS

TransIP DNS

Website info

HTTPS Ja

Languages EN, FR, NL

Features

Newsletter

Security

✓ HTTPS

✓ SPF

✓ DMARC

Network

✓ IPv6

Details

Company number: 0418.282.311
VAT number: BE 0418.282.311
Registered office: Haachtse Steenweg 53, 1210 Sint-Joost-ten-Node
Names & denominations: Viva Salud
Enterprise type: Rechtspersoon
Legal form: Non-profit association
Legal situation: Normale toestand
Start date: 1 February 1978
Peppol: Active · Active since 21 Oct 2026
Contact: vivasalud.be
Activities · NACE: Verenigingen op het vlak van ontwikkelingssamenwerking

View on CBE Public ↗ Annual accounts (NBB) ↗

Viva Salud

Financials

What happened to Viva Salud?

Management

Directors

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions